Yaohui Chen

No.37, Guoxue Valley, Wuhou District
Chengdu, 610041, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

Rewiring the Molecular Interplay of CDK4/6 Inhibitors in Lung Cancer: From Cell Cycle Control to Immune Microenvironment Remodeling.

Rewiring the Molecular Interplay of CDK4/6 Inhibitors in Lung Cancer: From Cell Cycle Control to Immune Microenvironment Remodeling.

Journal: International journal of molecular sciences

Published: July 07, 2026

Establishment and characterization of TRI-LC21: a novel patient-derived cell line of SMARCA4-deficient undifferentiated thoracic tumor.

Establishment and characterization of TRI-LC21: a novel patient-derived cell line of SMARCA4-deficient undifferentiated thoracic tumor.

Journal: Human cell

Published: May 20, 2026

LPIN2 contributes to tyrosine kinase inhibitor resistance via activation of PI3K pathway.

LPIN2 contributes to tyrosine kinase inhibitor resistance via activation of PI3K pathway.

Journal: Translational lung cancer research

Published: December 21, 2025

Lactate-Mediated Epigenetic and Immunometabolic Reprogramming in Glioma: An Emerging Axis Linking Metabolism to Tumor Progression.

Lactate-Mediated Epigenetic and Immunometabolic Reprogramming in Glioma: An Emerging Axis Linking Metabolism to Tumor Progression.

Journal: Biomedicines

Published: October 30, 2025

Iridium complex-loaded biomimetic vesicles enable enhanced photodynamic therapy and immune modulation.

Iridium complex-loaded biomimetic vesicles enable enhanced photodynamic therapy and immune modulation.

Journal: Microsystems & nanoengineering

Published: October 18, 2025

LOSTdb: a manually curated multi-omics database for lung cancer research.

LOSTdb: a manually curated multi-omics database for lung cancer research.

Journal: BMC bioinformatics

Published: July 02, 2025

RNase1-driven ALK-activation is an oncogenic driver and therapeutic target in non-small cell lung cancer.

RNase1-driven ALK-activation is an oncogenic driver and therapeutic target in non-small cell lung cancer.

Journal: Signal transduction and targeted therapy

Published: October 07, 2024

Dynamic ctDNA informs whole-course postoperative precise management of NSCLC (LUNGCA study).

Dynamic ctDNA informs whole-course postoperative precise management of NSCLC (LUNGCA study).

Journal: Journal of the National Cancer Institute

Published: September 22, 2024

Integrated analyses of multi-omic data derived from paired primary lung cancer and brain metastasis reveal the metabolic vulnerability as a novel therapeutic target.

Integrated analyses of multi-omic data derived from paired primary lung cancer and brain metastasis reveal the metabolic vulnerability as a novel therapeutic target.

Journal: Genome medicine

Published: September 17, 2024

Lactate and lysine lactylation of histone regulate transcription in cancer.

Lactate and lysine lactylation of histone regulate transcription in cancer.

Journal: Heliyon

Published: July 26, 2024

Corrigendum: Advances in oncolytic herpes simplex virus and adenovirus therapy for recurrent glioma.

Corrigendum: Advances in oncolytic herpes simplex virus and adenovirus therapy for recurrent glioma.

Journal: Frontiers in immunology

Published: December 09, 2023

Advances in oncolytic herpes simplex virus and adenovirus therapy for recurrent glioma.

Advances in oncolytic herpes simplex virus and adenovirus therapy for recurrent glioma.

Journal: Frontiers in immunology

Published: August 29, 2023

Showing 1-12 of 25

Last Updated: 09/26/2026